|
1
|
Epigenetic control.
|
J Cell Physiol
|
2009
|
1.85
|
|
2
|
MEIS C termini harbor transcriptional activation domains that respond to cell signaling.
|
J Biol Chem
|
2005
|
1.11
|
|
3
|
Epigenetic control of Hox genes during neurogenesis, development, and disease.
|
Ann Anat
|
2010
|
1.06
|
|
4
|
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.
|
Neural Plast
|
2012
|
1.02
|
|
5
|
Retrovirus silencing by an epigenetic TRIM.
|
Cell
|
2007
|
0.99
|
|
6
|
Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome.
|
Hum Mol Genet
|
2013
|
0.98
|
|
7
|
Loss of HLTF function promotes intestinal carcinogenesis.
|
Mol Cancer
|
2012
|
0.88
|
|
8
|
Rett syndrome and MeCP2.
|
Neuromolecular Med
|
2014
|
0.87
|
|
9
|
Beta2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species.
|
Int J Cancer
|
2003
|
0.87
|
|
10
|
The genetic and epigenetic journey of embryonic stem cells into mature neural cells.
|
Front Genet
|
2012
|
0.87
|
|
11
|
Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation.
|
J Biol Chem
|
2006
|
0.85
|
|
12
|
Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.
|
PLoS One
|
2012
|
0.85
|
|
13
|
Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis.
|
Dev Biol
|
2006
|
0.85
|
|
14
|
Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells.
|
Ann Anat
|
2013
|
0.84
|
|
15
|
Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
|
Oncogene
|
2002
|
0.78
|